Header Logo

Connection

ROSEMARIE SCHMANDT to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Receptor, ErbB-2.
ROSEMARIE SCHMANDT
Connection Strength
0.007
Receptor, ErbB-2
  1. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.